Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)

NCT05984147

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • Omega Cancer Hospitals Visakhapatnam, Andhra Pradesh, India
  • Post Graduate Institute of Medical Education & Research, Chandigarh, India
  • Cellcure Care Cancer Pvt Ltd Ahmedabad, Gujarat, India
  • HCC Happiness Care and Cure Multispeciality Hospital Ahmedabad, Gujarat, India
View all 27 locations
View Trial Details
Recruiting

Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader

NCT05294731

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +36 more
Locations
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Beijing Chao Yang Hospital,Capital Medical University Beijing, Beijing Municipality, China
View all 29 locations
View Trial Details
Recruiting

Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3)

NCT07496229

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
  • Henan Provincial People's Hospital Zhengzhou, Henan, China
View Trial Details
Recruiting

Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology

NCT06378190

Conditions
B-cell Lymphoma Recurrent, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Hospital Clínic Barcelona, Spain
  • Institut Català d'Oncologia Hospital L'Hospitalet de Llobregat, Barcelona, Spain
  • Fundación Jiménez Díaz Hospital Madrid, Spain
  • Virgen de la Arrixaca University Hospital El Palmar, Mur, Spain
View Trial Details

Related conditions